Novel Bis(1,2,4-oxadiazolyl) Fused Thiazole Derivatives: Synthesis and Anticancer Activity
- Авторы: Sateesh Kumar P.1, Umadevi P.1
-
Учреждения:
- Department of Chemistry, Gitam Institute of Sciences
- Выпуск: Том 88, № 12 (2018)
- Страницы: 2611-2615
- Раздел: Article
- URL: https://journals.rcsi.science/1070-3632/article/view/222603
- DOI: https://doi.org/10.1134/S107036321812023X
- ID: 222603
Цитировать
Аннотация
A novel series of bis-1,2,4-oxadiazole fused benzothiazole derivatives 9a–9j are synthesized, and their structures are confirmed by 1H and 13C NMR, and mass spectral data. All products are evaluated in vitro for their anticancer potential against a panel of four human cancer cell lines such as lung cancer (A549), breast carcinoma (MCF-7), melanoma (A375), and colon cancer (HT-29). The combretastatin-A4 is used as standard drug. All compounds 9a–9j exhibit significant anticancer activity with IC50 values ranging from 0.11±0.01 to 14.6±3.89 μM. Among these, compounds 9a–9d, 9h, 9i demonstrate more potent activity than the control.
Ключевые слова
Об авторах
P. Sateesh Kumar
Department of Chemistry, Gitam Institute of Sciences
Email: sateeshpinninti@rediffmail.com
Индия, Rushikonda, Vishakapatnam, 530045
P. Umadevi
Department of Chemistry, Gitam Institute of Sciences
Автор, ответственный за переписку.
Email: sateeshpinninti@rediffmail.com
Индия, Rushikonda, Vishakapatnam, 530045